Assays
Blogs
Perspectives from vivoVerse on C. elegans, predictive toxicology, New Approach Methodologies, microfluidics, and automated biological analysis.
Assays
Assays
Unlocking the Mysteries of Protein Aggregation: Insights from C. elegans
Explore how C. elegans and automated screening reveal the effects of dietary and pharmacological interventions on protein aggregation. July 31, 2025
Toxicology & NAMs
A Predictive NAM for Developmental Toxicity Testing
How vivoVerse combines C. elegans, microfluidics, automated imaging, and machine learning for scalable developmental toxicity testing. June 9, 2025
Company News
Tiny Titans of Science: The Nobel-Worthy Science of C. elegans
Four Nobel Prize-winning discoveries show how C. elegans has transformed genetics, cell biology, fluorescence imaging, and gene regulation. May 1, 2025
C. elegans
Why C. elegans Is a Powerful Model Organism in Biomedical Research
Caenorhabditis elegans (C. elegans), a tiny transparent roundworm, is one of the most widely used model organisms in scientific research. First introduced to the laboratory by Sydney Brenner in 1965,… April 25, 2025
C. elegans
C. elegans scientists awarded 2024 Nobel Prize in Medicine for their pioneering work discovering microRNA
The 2024 Nobel Prize in Physiology or Medicine was awarded to Victor Ambros and Gary Ruvkun for the discovery of microRNA, a small non-coding RNA molecule that plays a crucial… October 28, 2024
C. elegans
Nobel Nematode – A History of C. elegans as a Model Organism
How Sydney Brenner established C. elegans as a model organism and helped launch decades of influential research in genetics, neurobiology, aging, and toxicology. June 20, 2023
Toxicology & NAMs
C. elegans as a Model for Rapid, Cost-Effective Toxicology Assessments
How C. elegans combines practical, ethical, genetic, and predictive advantages for rapid, cost-effective toxicology screening. March 16, 2023No articles are currently assigned to this category.
